Introduction: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) syndrome is a recently described chronic inflammatory disease of the central nervous system. There are few reports of CLIPPERS in the Chinese population to date. We summarized the clinical characteristics of 6 CLIPPERS patients to deepen the understanding of this disease. Methods: The clinical manifestations and treatment of 6 CLIPPERS patients confirmed by pathology or clinical diagnosis in our hospital were retrospectively analyzed. Results: The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia, dizziness, cognitive impairment, facial paresthesia, and paralysis. Most of the lesions showed typical symmetric “pepper powder”-like dot and nodular enhancement centered in the pontine and cerebellum except 1 patient with unilateral nodular enhancement. The brain histopathological examination of the 5 biopsied patients indicated that, with the exception of patient 4 with no lymphocyte infiltration, a large amount of perivascular lymphocytic infiltration was found in the other 4 patients, among whom only 1 patient was dominated by CD3+ T cell infiltration and the other 3 patients were dominated by CD20+ B cell infiltration. After treatment with intravenous methylprednisolone, all patients had significant clinical recovery associated with complete or significant MRI recovery, but they were prone to relapse after withdrawal or reduction of the corticosteroid. Conclusion: Our reports highlight the importance of neuropathological examinations when encountering atypical imaging manifestations, such as unilateral and large nodular Gd+ lesions, in order to establish a final diagnosis of CLIPPERS. In addition, the lymphocytic infiltration in the lesions of CLIPPERS may be dominated by CD20+ B cells instead of CD3+ T cells.

1.
Pittock
SJ
,
Debruyne
J
,
Krecke
KN
,
Giannini
C
,
van den Ameele
J
,
De Herdt
V
, et al.
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
.
Brain
.
2010
;
133
(
9
):
2626
34
. .
2.
Yi
F
,
Tian
Y
,
Chen
XY
,
Zhou
Y
,
Hu
YC
,
Sun
Q
, et al.
Two cases of CLIPPERS with increased number of perivascular CD20-positive B lymphocytes
.
Brain
.
2018
;
141
(
10
):
e75
. .
3.
Tian
D
,
Zhu
X
,
Xue
R
,
Zhao
P
,
Yao
Y
.
Case 259: primary central nervous system lymphomatoid granulomatosis mimicking chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
.
Radiology
.
2018
;
289
(
2
):
572
7
. .
4.
Tobin
WO
,
Guo
Y
,
Krecke
KN
,
Parisi
JE
,
Lucchinetti
CF
,
Pittock
SJ
, et al.
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
.
Brain
.
2017
;
140
(
9
):
2415
25
. .
5.
Taieb
G
,
Mulero
P
,
Psimaras
D
,
van Oosten
BW
,
Seebach
JD
,
Marignier
R
, et al.
CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS
.
J Neurol Neurosurg Psychiatry
.
2019
;
90
(
9
):
1027
38
. .
6.
De Graaff
HJ
,
Wattjes
MP
,
Rozemuller-Kwakkel
AJ
,
Petzold
A
,
Killestein
J
.
Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
.
JAMA Neurol
.
2013
;
70
(
7
):
915
8
. .
7.
Taieb
G
,
Uro-Coste
E
,
Clanet
M
,
Lassmann
H
,
Benouaich-Amiel
A
,
Laurent
C
, et al.
A central nervous system B-cell lymphoma arising two years after initial diagnosis of CLIPPERS
.
J Neurol Sci
.
2014
;
344
(
1–2
):
224
6
. .
8.
Limousin
N
,
Praline
J
,
Motica
O
,
Cottier
JP
,
Rousselot-Denis
C
,
Mokhtari
K
, et al.
Brain biopsy is required in steroid-resistant patients with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
.
J Neurooncol
.
2012
;
107
(
1
):
223
4
. .
9.
Taieb
G
,
Allou
T
,
Labauge
P
.
Therapeutic approaches in CLIPPERS
.
Curr Treat Options Neurol
.
2017
;
19
(
5
):
17
. .
10.
Taieb
G
,
Duflos
C
,
Renard
D
,
Audoin
B
,
Kaphan
E
,
Pelletier
J
, et al.
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients
.
Arch Neurol
.
2012
;
69
(
7
):
847
55
. .
11.
Cipriani
VP
,
Arndt
N
,
Pytel
P
,
Reder
AT
,
Javed
A
.
Effective treatment of CLIPPERS with long-term use of rituximab
.
Neurol Neuroimmunol Neuroinflamm
.
2018
;
5
(
3
):
e448
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.